CONMED Corp — Director's Dealing 2011

May 3, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2011-04-29

Reporting Person: Cohen Heather L (VP CORP HR&DEPUTY GEN COUNSEL)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-04-29	Common Stock	M	1200	$25.89	Acquired	3343	Direct
2011-04-29	Common Stock	M	1000	$25.03	Acquired	4343	Direct
2011-04-29	Common Stock	S	2200	$28.5863	Disposed	2143	Direct
2011-04-29	Common Stock	M	2000	$19.93	Acquired	4143	Direct
2011-04-29	Common Stock	F	1631	$28.08	Disposed	2512	Direct
2011-04-29	Common Stock	M	2000	$16.46	Acquired	4512	Direct
2011-04-29	Common Stock	F	1473	$28.08	Disposed	3039	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-04-29	Options To Purchase Common Stock	$25.89	M	1200	Disposed	2012-05-14	Common Stock (1200)	Direct
2011-04-29	Options To Purchase Common Stock	$25.03	M	1000	Disposed	2014-05-18	Common Stock (1000)	Direct
2011-04-29	Sars (Stock Appreciation Rights)	$19.93	M	2000	Disposed	2016-05-16	Common Stock (2000)	Direct
2011-04-29	Sars (Stock Appreciation Rights)	$16.46	M	2000	Disposed	2019-06-01	Common Stock (2000)	Direct

Footnotes

F1: 5 year vesting schedule, 20% vest each year starting 5/14/2003.

F2: 5 year vesting schedule, 20% vest each year starting 5/18/2005.

F3: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.

F4: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.